SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page123456Next Page
2026-05-22CRBP3Form 3 Filing for Corbus Pharmaceuticals Holdings, Inc.MEDIUM
This filing is an initial statement of beneficial ownership of securities filed by Nishant Saxena, Chief Business Officer of Corbus Pharmaceuticals Holdings, Inc. The filing indicates that Mr. Saxena, through his attorney-in-fact Meghan Houghton, directly owns 3,500 shares of Corbus Pharmaceuticals Holdings, Inc. commo...
Micro CapBiotechnology
Previous Page123456Next Page